The Latest Cardiac and Vascular News
The fast, accurate, and proven RapidAI platform improves patient and staff experience and diagnostic accuracy, ensures high care team coordination, better health outcomes, and reduces costs. SAN ANTONIO, Sept. 12, 2022 /PRNewswire/ — Frost & Sullivan recently analyzed the artificial intelligence (AI) algorithms for the stroke market, and, based on its assessment results, recognizes RapidAI with the 2022 Global Technology Innovation […]
The technology used in the Rapid® platform is highly unique and scalable and can deliver exceptional cost efficiencies to hospitals of all sizes SANTA CLARA, Calif., Feb. 10, 2021 /PRNewswire/ — Based on its recent analysis of the global intelligent imaging analysis systems market, Frost & Sullivan recognizes RapidAI with the 2020 Global Growth, Innovation & Leadership Frost Radar Award for […]
LONDON, Nov. 6, 2018 /PRNewswire/ — Based on its recent analysis of the global cardiac protein biomarker research market, Frost & Sullivan recognises Olink Proteomics with the 2018 Global Enabling Technology Leadership Award for developing its cardiovascular (CV) multiplex panels—CVD II and CVD III—featuring its proprietary Proximity Extension Assay (PEA) technology. The CVD II and CVD III panels enable […]
LONDON, Aug. 31, 2017 /PRNewswire/ — Frost & Sullivan is pleased to recognize PQ Bypass with the 2017 European PAD Interventions Technology Innovation Award. PQ Bypass’ DETOUR System is a minimally invasive technology that enables physicians to re-direct, or detour, blood flow around extremely long blockages in the upper leg arteries to restore blood flow to the lower […]
